Themis Medicare Share Price

    NSE
    126.44
    -3.45 (2.35%)
    THEMISMED • 09 Jul, 2025 | 12:37 PM
    BUY

    1Y Annualised Return

    -45.94%

    3Y Annualised Return

    17.14%

    5Y Annualised Return

    27.62%

    The current prices are delayed, login or Open Demat Account for live prices.

    Themis Medicare Stock Performance

    1W Return1.09
    1Y Return-47.17
    Today's Low126.5
    Prev. Close129.89
    Mkt Cap (Cr.)1,195.51
    1M Return-12.36
    3Y Return57.62
    52-Week High317
    Open129.05
    PE Ratio49.98
    6M Return-53.20
    Today's High130
    52-Week Low115
    Face Value1

    Themis Medicare Company background

    Founded in: 1969
    Managing director: Sachin D Patel
    Themis Medicare Limited was formerly incorporated as Themis Chemicals Limited in 1969. The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993. Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001. The Group is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.In Mar.95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansioncummodernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment longterm working capital.Total cost of the project was estimated at Rs 17.64 cr. TCL manufactures and sells synthetic bulk drugs and formulations. It operates in the therapeutic segments of antituberculosis, cerebroactivators, bronchodilators, antiasthmatic, anaesthetic and other segments.Antituberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment. TCL has also started manufacturing and exporting fumagillin, an antibacterial drug, for veterinary use for which it has a confirmed buyback arrangement with Chinoin, Hungary.The company with the help of M/s Pharmograd,Moscow a manufacturing unit, is planning to market its AntiT.B.formulation products through the collborators throughout the Russian Federation for trade,tenders and govt.supplies.The Company introduced products like Cardiac and Muscular Relaxant during the year 200102. A wholly owned subsidiary of the Company, Themis Medicare Singapore Pte. Ltd., formed on 22nd May, 2002 in Singapore became operational during the year 200203. M/s. Artemis Biotech Ltd., a Group Company was merged with Themis Medicare Ltd. (the Parent Company) with effect from 1st April 2003. The Joint Venture Company, Richter Themis Medicare (India) Pvt. Ltd. started manufacturing activities at its EOU unit at Vapi effective from March, 2006. The Company started operations of its new Injection Plant at Haridwar for tablets and gel formulation production in 200607. Themiseal, the Companys unique haemostatic and antimicrobial product was launched in the UK, Greece, Cyprus, Jordan, Romania and Indonesia.During the year 201011, a Private Ltd Subsidiary Company in the name and style of Themis Lifestyle Pvt. Ltd was incorporated on 3rd November, 2010 and another Public Ltd Subsidiary Company in the name and style of Artemis Biotech Ltd. was incorporated on 14th January, 2011.During FY 201617, HIDPUL KFT (Hungary), a Wholly Owned Subsidiary of the Company, ceased to be a subsidiary of the Company. Carpo Medical Limited was incorporated as a Joint Venture Company in the United Kingdom in 201617.The Company launched a new product Lenzetto Global brand of Estradiol Novel Drug Delivery System for treatment of Menopausal symptoms in 2023. As part of a strategy to concentrate on both the API and the Hospital Business, the Company demerged the API segment of the Company, including both the API production facilities, to a 100% owned subsidiary company, Themis Lifestyle Private Limited through slump sale in 2023.

    As of 09 Jul, 2025, Themis Medicare share price is ₹127. The stock opened at ₹129 and had closed at ₹129.9 the previous day. During today’s trading session, Themis Medicare share price moved between ₹126.50 and ₹130.00, with an average price for the day of ₹128.25. Over the last 52 weeks, the stock has recorded a low of ₹115.00 and a high of ₹317.00. In terms of performance, Themis Medicare share price has declined by 53.9% over the past six months and has declined by 45.94% over the last year.

    Read More
    Themis Medicare SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹52,05,982 (-19.91%)

    Daily SIP of 25,000 would have become 52,05,982 in 1 year with a gain of -12,94,017 (-19.91%)

    View details of Market Depth

    Themis Medicare Fundamental

    Market Cap (in crs)

    1,195.51

    Face Value

    1

    Turnover (in lacs)

    104.35

    Key Metrics

    Qtr Change %
    59.95% Fall from 52W High
    -0.8
    Dividend yield 1yr %
    Below industry Median
    0.4

    Themis Medicare Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Themis Medicare Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    71.7 Cr
    93.81 Cr
    117.01 Cr
    122.99 Cr
    97.82 Cr
    Themis Medicare Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    410.18 Cr
    386.52 Cr
    365.83 Cr
    401.16 Cr
    234.29 Cr
    205.05 Cr
    Themis Medicare Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    -7.75 Cr
    3.08 Cr
    9.87 Cr
    18.71 Cr
    3.07 Cr
    Themis Medicare Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    23.91 Cr
    24.72 Cr
    43.28 Cr
    61.54 Cr
    26.23 Cr
    15.88 Cr

    Themis Medicare Result Highlights

    • Themis Medicare Ltd reported a 4.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 19.1%.

    • Its expenses for the quarter were up by 3.5% QoQ and 24.8% YoY.

    • The net profit increased 1176.9% QoQ and decreased 21.0% YoY.

    • The earnings per share (EPS) of Themis Medicare Ltd stood at 0.7 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Themis Medicare

    Promoter
    67.2%
    Foreign Institutions
    0.1%
    Public
    32.8%
    Promoter
    67.2%
    Foreign Institutions
    0.1%
    Domestic Institutions
    0.1%
    Public
    32.7%
    Promoter
    67.2%
    Foreign Institutions
    0.1%
    Public
    32.8%
    Promoter
    67.2%
    Foreign Institutions
    0.1%
    Public
    32.7%
    Promoter
    67.2%
    Domestic Institutions
    0.1%
    Public
    32.8%
    Promoter
    67.2%
    Public
    32.8%

    Themis Medicare Technical Analysis

    Moving Averages Analysis
    126.44
    Current Price
    Bullish Moving Averages
    1
    Bearish Moving Averages
    15
    5Day EMA
    127.60
    10Day EMA
    128.60
    12Day EMA
    129.20
    20Day EMA
    131.20
    26Day EMA
    132.30
    50Day EMA
    137.50
    100Day EMA
    155.00
    200Day EMA
    180.90
    5Day SMA
    126.40
    10Day SMA
    128.40
    20Day SMA
    132.40
    30Day SMA
    134.30
    50Day SMA
    135.40
    100Day SMA
    145.60
    150Day SMA
    184.10
    200Day SMA
    206.70
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    177619 Rs
    345356 Rs
    Week Rs
    125280 Rs
    239345 Rs
    Month Rs
    85866 Rs
    176838 Rs
    129.11
    Pivot
    Resistance
    First Resistance
    132.67
    Second Resistance
    135.46
    Third Resistance
    139.02
    Support
    First Support
    126.32
    Second support
    122.76
    Third Support
    119.97
    Relative Strength Index
    45.75
    Money Flow Index
    46.21
    MACD
    -3.14
    MACD Signal
    -2.80
    Average True Range
    5.90
    Average Directional Index
    10.62
    Rate of Change (21)
    -10.33
    Rate of Change (125)
    -49.88

    Themis Medicare Latest News

    08 JUL 2025 | Tuesday

    Themis Medicare Ltd - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    26 JUN 2025 | Thursday

    Themis Medicare Ltd - 530199 - Closure of Trading Window

    13 JUN 2025 | Friday

    Themis Medicare Ltd - 530199 - Announcement Under Regulation 30 Of SEBI (LODR)- Withdrawal Of Scheme Of Amalgamation.

    View More

    Themis Medicare Share Price FAQs

    Themis Medicare share price is ₹126.44 in NSE and ₹126.6 in BSE as on 9/7/2025.

    Themis Medicare share price in the past 1-year return was -47.16. The Themis Medicare share hit a 1-year low of Rs. 115 and a 1-year high of Rs. 317.

    The market cap of Themis Medicare is Rs. 1195.51 Cr. as of 9/7/2025.

    The PE ratios of Themis Medicare is 49.98 as of 9/7/2025.

    The PB ratios of Themis Medicare is 4.16 as of 9/7/2025

    You can easily buy Themis Medicare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Themis Medicare share price is ₹317 and ₹115 as of 9/7/2025.

    Please be aware that Themis Medicare stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    66.44
    +0.18 (+0.27%)
    137.95
    -0.25 (-0.18%)
    690.90
    -2.30 (-0.33%)
    2,583.30
    -8.00 (-0.31%)
    164.65
    -1.83 (-1.10%)
    389.00
    +2.50 (+0.65%)
    158.46
    -3.51 (-2.17%)
    264.75
    +1.25 (+0.47%)
    420.50
    -1.50 (-0.36%)
    401.35
    +0.50 (+0.12%)
    Top Gainers
    681.25
    +12.30 (+1.84%)
    2,428.70
    +36.00 (+1.50%)
    333.10
    +4.25 (+1.29%)
    939.00
    +11.35 (+1.22%)
    3,187.70
    +29.80 (+0.94%)
    Top Losers
    158.12
    -3.85 (-2.38%)
    671.65
    -13.95 (-2.03%)
    1,681.00
    -27.10 (-1.59%)
    265.70
    -3.95 (-1.46%)
    785.45
    -8.70 (-1.10%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -